相关实验视频

Updated: Jul 6, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

在老年人中优化他类药物治疗:对剂量,定位和组合策略的系统审查

Anna Artner^1,2, Romána Zelkó^3,4, Balázs Hankó^5,6

¹Center of Pharmacology and Drug Research & Development, Semmelweis University, Budapest, 1085, Hungary.

|July 15, 2025

概括

类药物有效降低老年人心血管疾病的风险. 个性化剂量和组合疗法最大限度地提高了益处,同时最大限度地降低了诸如拉布地质溶解等副作用.

科学领域:

老年医学老年医学
心脏病学心脏病学
药理学药理学是指药理学的学科.

背景情况:

类药物对于控制动脉样硬化心血管疾病 (ASCVD) 风险至关重要.
狂犬病是他类药物的严重副作用,特别是在脆弱的老年人中,他们有多种健康问题和药物.
目前对于老年人服用他类药物的剂量调整的指导方针尚不清楚.

研究的目的:

系统地审查老年人群中他类药物的使用情况.
评估老年人使用他类药物治疗的益处风险比率.
为了分析这个人口群体的最佳他类药物剂量方案.

主要方法:

在主要的科学数据库 (PubMed,Scopus,Web of Science,EBSCO) 进行了系统的文献审查.
这项分析包括11项原始研究,包括566,509名患者.
审查协议已在PROSPERO (CRD42024587259) 中注册.

主要成果:

与安慰剂相比,他类药物治疗表明心血管疾病 (CVD) 的风险降低.
高强度的他类药物,当在治疗期间进行调整时,比具有类似副作用的固定低剂量疗法提供更大的益处.
结合治疗以埃泽提米布和他类药物改善了结果,并减少了副作用.
对老年人来说,改善执着的策略至关重要.

结论:

对老年人来说,个性化的他类药物剂量,包括定位和组合疗法,至关重要.
个性化坚持策略对于最大限度地提高治疗效益和最大限度地降低风险至关重要.
在给老年人处方他类药物时,需要仔细考虑患者特异性因素,以有效降低心血管疾病风险.

关键词:

心血管疾病是什么心血管疾病组合疗法是一种联合疗法.剂量调整剂量调整年长的老人.达丁类药物治疗疗法定位定位定位定位定位

更多相关视频

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

相关概念视频

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Dosage Regimen: Individualization

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...

Drug Dosing: Geriatric Patients

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...